Medyceles

Medyceles is a joint venture between South Korean biopharmaceutical leader Medytox and Thai aesthetics distributor Celeste. Established in 2017 and headquartered in Bangkok, the company specializes in the marketing and distribution of medical aesthetics products across Thailand and Southeast Asia. Its core portfolio includes the botulinum toxin brands Neuronox and Innotox, as well as the Neuramis line of hyaluronic acid dermal fillers. Medyceles plays a dominant role in the Thai aesthetics market, leveraging Medytox's R&D expertise and Celeste's extensive local distribution network to provide high-quality, clinically validated aesthetic solutions.